Actinium Pharmaceuticals Inc.

06/15/2021 | Press release | Distributed by Public on 06/15/2021 06:45

Safety Data Highlighting Low Rates of Adverse Events and Non-Relapse Transplant Related Mortality in Patients Receiving Iomab-B Presented at 2021 SNMMI Virtual Conference